Call Us08045479576
Bisoprolol Fumarate

Bisoprolol Fumarate

16000 INR/Kilograms

Product Details:

  • Storage Room Temperature
  • Shelf Life 5 Years
  • Taste Odorless
  • EINECS No 600-557-5
  • Structural Formula C18H31NO4
  • Molecular Weight 441.52 Grams (g)
  • Heavy Metal (%) Not Available
  • Click to View more
X

Bisoprolol Fumarate Price And Quantity

  • 16000 INR/Kilograms
  • 16000.00 - 18000.00 INR/Kilograms
  • 25 Kilograms

Bisoprolol Fumarate Product Specifications

  • C18H31NO4
  • 5 Years
  • Odorless
  • 600-557-5
  • Room Temperature
  • Bisoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication belongs to a class of drugs known as beta blockers.
  • Medicine Grade
  • >20 mg/mL in DMSO
  • 104344-23-2
  • 441.52 Grams (g)
  • Not Available
  • 29420090
  • 1.2 - 7.5
  • Solid
  • Other
  • Not Available
  • 445
  • 100
  • bisoprolol fumarate
  • Not Available
  • C22H35NO8
  • Bisoprolol Fumarate()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2 butenedioate (2:1) (salt).
  • 98%
  • Pharmaceutical Intermediates

Bisoprolol Fumarate Trade Information

  • Mumbai
  • Letter of Credit at Sight (Sight L/C) Letter of Credit (L/C) Delivery Point (DP) Days after Acceptance (DA) Cash in Advance (CID) Cash Advance (CA)
  • 100 Kilograms Per Day
  • 7 Days
  • Yes
  • Free samples are available
  • Drum packing
  • Australia South America Eastern Europe Western Europe Middle East Central America Asia North America Africa
  • All India
  • GMP and ISO

Product Description

Bisoprolol Fumarate and Intermediates of Bisoprolol Fumarate in our range are manufactured under GMP site with all types of regulatory supports. We, the manufacturing company supplies it not only in Indian states, but different countries as well. 

Bisoprolol Fumarate Properties:

  • CAS No.: 104344-23-2
  • Formula: C18H31NO4.C4H4O4
  • Molecular Weight: 441.52
  • Synonyms: (+-)-1-(p-((2-Isopropoxyethoxy)methyl)phenoxy)-3-isopropylamino-2-propanol hemifumarate; Monocor;Soprol;2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, (E)-2-butenedioate (2: 1) (salt); Bisoprolol hemifumarate;2-Propanol,1-[4-[[2-(1-methylethoxy)ethoxy]- methyl]phenoxy]-3-[(1-methylethyl)amino]-,(2E)-2-butenedioate (2: 1) (salt);but-2-enedioic acid; 1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol;Concor
  • Density: 1.033 g/cm3
  • Melting Point: 100 C
  • Boiling Point: 445 C at 760 mmHg
  • Flash Point: 222.9 C
  • Solubility: >20 mg/mL in DMSO
  • Appearance: White to off-white powder

Uses:


Beta-1 adrenergic blockers like bisoprolol are prescribed to prevent myocardial infarction, protect against heart failure, and treat mild to moderate hypertension. 

How does it work:


A beta blocker such as bisoprolol is a type of medicine. Like other beta blockers, bisoprolol blocks some nerve impulses in the body, especially those that affect your heart. As a result, your heart rate goes down and your blood is easier to pump.

Applications. Or where it is used:


It is used in combination with or without other medications in the treatment of high blood pressure (hypertension). Managing high blood pressure reduces the risk of strokes, heart attacks and kidney disease.

Manufacturing process:


Distillation can be used to purify bisoprolol. Crystallisation is another option for purifying bisoprolol base. Bisoprolol base and fumaric acid may be reacted to form bisoprolol fumarate. In one embodiment, the process consists of converting bisoprolol fumarate to bisoprolol base.

How to use:


Bisoprolol Fumarate 5 Mg Tablet Beta-Blocker must be taken by mouth with or without food, in dosage recommended by your doctor. 

Dosage of usage:


Adult dosage (ages 1864 years)
  • Typical starting dosage: 5 mg taken once per day.
  • Dosage increases: The doctor may increase your dose to 10 mg once daily if you don't respond to that dose.
  • Maximum dosage: 20 mg per day.

Child dosage (ages 017 years)
  • We don't know the best dosage for this age group.

Senior dosage (ages 65 years and older)
  • The organs in your body (such as the kidneys or liver) may no longer function as well as they used to. This allows the drug to stay in your body longer. It is possible for your doctor to begin with a lower dose.

Special dosage considerations
  • For people with asthma or respiratory disease: Bisoprolol is likely to begin with 2.5 mg daily and be gradually increased. An excessive dosage of bisoprolol may affect your lungs in addition to your heart.
  • For people with kidney problems: To begin with, your doctor may prescribe you 2.5 mg of bisoprolol daily. Increases in dosage will be carefully monitored by your doctor.
  • For people with liver problems: You may be prescribed bisoprolol 2.5 mg twice a day by your doctor. It is important to talk to your doctor before increasing your dosage.

Side effects:


Common side effects include:
  • Upper respiratory infection
  • Diarrhea
  • Dizziness
  • Insomnia
  • Slow, irregular heartbeats
  • Runny or stuffy nose
  • Sore throat
  • Sinus infection (sinusitis)
  • Vomiting
  • Tiredness
  • Joint pain
  • Cough
  • Weakness
  • Sleep problems (insomnia)
  • Anxiety
  • Shortness of breath
  • Nausea
  • Drowsiness
  • Lightheadedness upon standing
  • Spinning sensation (vertigo)
  • Dry mouth
  • Stomach pain
  • Constipation
  • Increased urination
  • Ringing in your ears
  • Restless feeling
  • Muscle pain
  • Itching or skin rash
  • Loss of interest in sex

Less common side effects include:
  • Depression
  • Cold extremities
  • Low blood pressure (hypotension)
  • Indigestion
  • Bronchospasm

Rare but serious side effects include:
  • Fainting
  • Blue fingers/toes
  • Trouble breathing
  • Very slow heartbeat
  • Severe dizziness
  • Mental/mood changes 

Other side effects include:
  • Mask symptoms of low blood sugar (hypoglycemia)
  • Decreased exercise tolerance
  • Raynaud's phenomenon
  • Aggravate congestive heart failure (CHF)
  • Decrease HDL
  • Hypertriglyceridemia
  • May increase triglyceride levels and insulin resistance

Warnings and precautions while using this product:


Warnings

Bisoprolol is the active ingredient in this medication. Please avoid taking medication if you are allergic to the drug's ingredients, including bisoprolol.
Keep away from children. Contact the Poison Control Center if you overdose.

Contraindications

Sinus bradycardia, 2/3 heart block, hypersensitivity, sick sinus syndrome without permanent pacemaker, cardiogenic shock, overt cardiac failure

Effects of Drug Abuse

Avoid chronic use; might cause laxative dependence

Pregnancy and Lactation

Pregnant women should use bisoprolol with caution when benefits outweigh risks. 
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category